FAT1 and pancreatic adenocarcinoma: With respect to FAT1, as noted in the Introduction, some cancers such as pancreatic adenocarcinomas overexpress FAT1 57 while studies in breast cancer provide mixed conclusions, with reports of mutational loss contrasting with findings of overexpression.